Chemoinformaics analysis of 1,5-Dimethylcyclopentene
Molecular Weight | 96.173 | nRot | 0 |
Heavy Atom Molecular Weight | 84.077 | nRig | 5 |
Exact Molecular Weight | 96.0939 | nRing | 1 |
Solubility: LogS | -3.304 | nHRing | 0 |
Solubility: LogP | 3.28 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 19.6915 |
nHD | 0 | BPOL | 12.0385 |
QED | 0.406 |
Synth | 3.421 |
Natural Product Likeliness | 2.373 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -4.288 |
MDCK | 0.0000229 |
BBB | 0.936 |
PPB | 0.926411 |
VDSS | 3.5 |
FU | 0.0802661 |
CYP1A2-inh | 0.817 |
CYP1A2-sub | 0.836 |
CYP2c19-inh | 0.167 |
CYP2c19-sub | 0.881 |
CYP2c9-inh | 0.058 |
CYP2c9-sub | 0.792 |
CYP2d6-inh | 0.053 |
CYP2d6-sub | 0.797 |
CYP3a4-inh | 0.06 |
CYP3a4-sub | 0.287 |
CL | 13.599 |
T12 | 0.428 |
hERG | 0.012 |
Ames | 0.015 |
ROA | 0.045 |
SkinSen | 0.394 |
Carcinogencity | 0.692 |
EI | 0.992 |
Respiratory | 0.197 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.954874 |